{"acute graft versus host disease": 231.29, "acute graft versus host disease in intestine": 182.45, "acute graft versus host disease in liver": 135.24, "acute graft versus host disease in skin": 269.77, "acute kidney injury": 2.38, "acute myeloid leukaemia": 9.44, "acute myeloid leukaemia recurrent": 34.91, "acute respiratory distress syndrome": 12.54, "adenovirus infection": 84.43, "aplasia pure red cell": 3.74, "aplastic anaemia": 40.03, "ascites": 4.1, "aspergillus infection": 21.64, "autoimmune haemolytic anaemia": 11.67, "bacteraemia": 29.69, "bacterial infection": 6.6, "bacterial sepsis": 25.1, "bk virus infection": 120.78, "blood bilirubin increased": 3.97, "blood follicle stimulating hormone increased": 536.13, "blood lactate dehydrogenase increased": 2.94, "blood luteinising hormone increased": 571.56, "bone marrow failure": 14.68, "bronchiectasis": 17.34, "bronchopulmonary aspergillosis": 26.74, "candida infection": 5.87, "cardiotoxicity": 8.22, "cerebral toxoplasmosis": 59.62, "chloroma": 109.28, "chronic graft versus host disease": 167.29, "chronic graft versus host disease in liver": 65.99, "chronic graft versus host disease in skin": 108.17, "clostridium difficile colitis": 13.33, "clostridium difficile infection": 5.95, "congenital aplasia": 13.28, "cystitis haemorrhagic": 215.6, "cytomegalovirus chorioretinitis": 56.94, "cytomegalovirus infection": 58.44, "cytomegalovirus infection reactivation": 150.85, "cytomegalovirus test positive": 47.77, "cytomegalovirus viraemia": 128.82, "cytopenia": 6.02, "device related infection": 4.53, "diffuse alveolar damage": 39.6, "disease recurrence": 2.31, "disseminated intravascular coagulation": 4.27, "disseminated toxoplasmosis": 474.52, "drug ineffective for unapproved indication": 3.75, "dysbiosis": 34.53, "encephalitis": 3.79, "encephalopathy": 3.05, "engraftment syndrome": 229.85, "enterococcal bacteraemia": 46.15, "enterococcal infection": 19.67, "epstein-barr viraemia": 186.0, "epstein-barr virus infection": 39.04, "epstein-barr virus infection reactivation": 61.12, "escherichia infection": 8.48, "febrile neutropenia": 18.37, "fungal infection": 7.82, "gastrointestinal infection": 9.18, "glomerulonephritis membranous": 23.96, "graft versus host disease": 152.18, "graft versus host disease in gastrointestinal tract": 75.12, "graft versus host disease in liver": 38.66, "graft versus host disease in skin": 127.1, "granulocytopenia": 6.36, "haematuria": 3.15, "haemophagocytic lymphohistiocytosis": 11.15, "haemorrhage intracranial": 2.06, "hepatic failure": 4.49, "hepatic necrosis": 15.91, "hepatomegaly": 6.07, "hepatotoxicity": 3.43, "herpes simplex": 7.97, "human herpesvirus 6 infection": 64.21, "hyperbilirubinaemia": 4.92, "hypoxia": 2.56, "idiopathic pneumonia syndrome": 161.67, "infection": 4.85, "infection reactivation": 38.09, "jc virus infection": 31.03, "klebsiella infection": 24.7, "leukaemia recurrent": 82.84, "lung disorder": 2.69, "mouth ulceration": 3.2, "mucormycosis": 31.41, "mucosal inflammation": 49.45, "multiple organ dysfunction syndrome": 13.25, "myelodysplastic syndrome": 9.56, "myelosuppression": 3.52, "nephropathy toxic": 3.56, "neurotoxicity": 4.6, "neutropenia": 2.15, "obliterative bronchiolitis": 33.66, "off label use": 4.22, "ovarian atrophy": 2046.68, "ovarian failure": 363.58, "pancytopenia": 7.23, "pericardial effusion": 3.39, "pleural effusion": 2.11, "pneumocystis jirovecii pneumonia": 4.46, "pneumonia": 2.36, "pneumonia cytomegaloviral": 43.46, "pneumonia fungal": 21.0, "pneumonitis": 2.92, "polyomavirus viraemia": 156.52, "post transplant lymphoproliferative disorder": 35.29, "posterior reversible encephalopathy syndrome": 14.71, "premature menopause": 102.0, "primary hypogonadism": 834.28, "product administered to patient of inappropriate age": 11.69, "product use in unapproved indication": 13.51, "progressive multifocal leukoencephalopathy": 12.08, "pseudomonas infection": 9.16, "pulmonary alveolar haemorrhage": 14.57, "pulmonary arterial hypertension": 3.94, "pulmonary haemorrhage": 11.41, "pulmonary hypertension": 5.42, "pulmonary veno-occlusive disease": 134.06, "rash maculo-papular": 2.02, "recurrent cancer": 23.29, "renal tubular injury": 50.24, "respiratory distress": 2.32, "respiratory failure": 7.61, "respiratory syncytial virus infection": 2.89, "retinitis viral": 313.01, "right ventricular failure": 4.95, "second primary malignancy": 4.56, "sepsis": 7.81, "septic shock": 7.06, "staphylococcal bacteraemia": 12.22, "staphylococcal infection": 6.69, "staphylococcal sepsis": 17.31, "stomatitis": 9.74, "testicular atrophy": 185.23, "thrombocytopenia": 4.29, "thrombotic microangiopathy": 52.13, "thrombotic thrombocytopenic purpura": 7.05, "toxic skin eruption": 3.5, "toxicity to various agents": 2.16, "toxoplasmosis": 49.6, "transplant failure": 135.47, "transplant rejection": 11.44, "tubulointerstitial nephritis": 5.29, "varicella zoster virus infection": 13.77, "venoocclusive disease": 326.1, "venoocclusive liver disease": 386.16, "viral haemorrhagic cystitis": 171.5, "viral infection": 4.47}